Curtis Dale's Insider Trades & SAST Disclosures

Curtis Dale's most recent trade in Alaunos Therapeutics Inc was a trade of 3,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on March 29, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Alaunos Therapeutics Inc
Dale Curtis Hogue Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Mar 2025 3,000 3,000 - - Employee Stock Option (right to buy)
Alaunos Therapeutics Inc
Curtis Dale Hogue Director, Interim CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Jan 2024 600,000 600,000 - - Employee Stock Option (right to buy)
Alaunos Therapeutics Inc
Dale Curtis Hogue Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Dec 2023 150,000 150,000 - - Employee Stock Option (right to buy)
Alaunos Therapeutics Inc
Curtis Dale Hogue Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Dec 2023 41,667 41,667 - - Employee Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades